Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.970
+0.090 (3.13%)
Nov 5, 2024, 10:14 AM EST - Market open
Editas Medicine Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 245 | 827 | 597 | 1,796 | 4,335 | 1,502 | |
Market Cap Growth | -55.96% | 38.68% | -66.78% | -58.56% | 188.64% | 38.90% | |
Enterprise Value | 11 | 416 | 139 | 1,168 | 3,820 | 1,187 | |
Last Close Price | 2.88 | 10.13 | 8.87 | 26.55 | 70.11 | 29.61 | |
PE Ratio | - | -5.02 | -2.76 | -9.33 | -35.43 | -11.07 | |
PS Ratio | 3.83 | 10.59 | 30.27 | 70.31 | 47.77 | 73.14 | |
PB Ratio | 1.35 | 2.37 | 1.65 | 3.24 | 11.01 | 5.72 | |
P/FCF Ratio | -1.47 | -6.04 | -3.29 | -10.46 | -23.18 | -32.06 | |
P/OCF Ratio | -1.54 | -6.26 | -3.36 | -10.96 | -24.10 | -36.92 | |
EV/Sales Ratio | 0.18 | 5.32 | 7.07 | 45.71 | 42.10 | 57.80 | |
EV/EBITDA Ratio | 0.00 | -2.55 | -0.63 | -6.21 | -29.19 | -8.59 | |
EV/EBIT Ratio | 0.00 | -2.46 | -0.62 | -6.05 | -28.33 | -8.42 | |
EV/FCF Ratio | 0.00 | -3.04 | -0.77 | -6.80 | -20.43 | -25.34 | |
Debt / Equity Ratio | 0.22 | 0.10 | 0.12 | 0.05 | 0.07 | 0.11 | |
Debt / FCF Ratio | -0.20 | -0.27 | -0.24 | -0.15 | -0.14 | -0.62 | |
Asset Turnover | 0.15 | 0.15 | 0.03 | 0.04 | 0.17 | 0.04 | |
Quick Ratio | 3.67 | 5.27 | 5.81 | 10.67 | 7.01 | 7.63 | |
Current Ratio | 3.75 | 5.39 | 5.94 | 10.82 | 7.20 | 7.74 | |
Return on Equity (ROE) | -78.56% | -43.17% | -48.22% | -40.65% | -35.36% | -53.65% | |
Return on Assets (ROA) | -34.32% | -20.87% | -23.70% | -19.31% | -15.59% | -18.96% | |
Return on Capital (ROIC) | -46.89% | -26.76% | -28.68% | -24.15% | -23.70% | -31.45% | |
Earnings Yield | -88.57% | -18.52% | -36.95% | -10.72% | -2.68% | -8.91% | |
FCF Yield | -80.49% | -16.55% | -30.42% | -9.56% | -4.31% | -3.12% | |
Buyback Yield / Dilution | -13.03% | -10.63% | -1.55% | -15.37% | -17.26% | -6.13% | |
Total Shareholder Return | -13.03% | -10.63% | -1.55% | -15.37% | -17.26% | -6.13% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.